Paola Lovato finished her Ph.D. at Pavia & Copenhagen University in 2003 and after a couple of years working at the university as a Post Doc Fellow, she got the opportunity to join Skin Research at LEO Pharma where she worked in the pre-clinical phase of drug development. As a pre-clinical research scientist, her job is mostly focused on elucidating immunoinflammatory processes within disease and drug mechanisms of action, and together with my colleagues, She understands the disease and the target that our drug is supposed to be raised against. In addition to that, need to understand how the activities in the disease and the target interact and hence, how the drug works. To this end, identify and drive explorative and experimental initiatives to create models that replicate disease features and target biology and hence, can be used to further disease understanding and target validation.
A vital aspect of Paola's job is to be updated on the scientific advances of relevance for disease and target understanding as well as to discuss with her colleagues the learnings acquired while working. Together she presents and challenges ideas and goes through project outlines and experiment outcomes. It is a team endeavor. Indeed, innovation is driven by diversity and hence acceptance and inclusion of diversity, curiosity towards each other skills and ideas, and finally team challenge and support are key for a successful project. Furthermore, working as a team is also fun – so a clear win-win situation. Together with her colleagues, we support the implementation of an innovation culture that can manage the risk that comes with working with first-in-class target projects.